Dr. Reddy's Laboratories Ltd. Fundamental & Technical Research, Share Price Today

NSE : DRREDDY
NIFTY : Nifty 50
NIFTY SECTOR : Nifty Pharma

About Company

Dr. Reddy’s Laboratories Limited commenced its generics business in India in 1986 and is currently a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas. The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.

Market Cap. ₹ 101,804 Cr.

52 Week - High/Low ₹ 1,421/1,020

P/E Ratio 18.64

P/B Ratio 4.12

Enterprise Value ₹ 99,131 Cr.

ROE % 19.54

RSI Value 62.96

EMA 50 1174.77

EMA 200 1220.5

Market Cap. ₹ 101,804 Cr.

52 Week - High/Low ₹ 1,421/1,020

P/E Ratio 17.63

P/B Ratio 3.53

Enterprise Value ₹ 98,003 Cr.

ROE % 21.76

RSI Value 62.96

EMA 50 1174.77

EMA 200 1220.5

Add Parameters

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Terms | Privacy | Contact Us